This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human Fas/TNFRSF6/CD95 Quantikine ELISA Kit
catalog :
DFS00
quantity :
1 Kit
price :
615 USD
citations: 17
Reference
Grzanka R, Damasiewicz Bodzek A, Kasperska Zajac A. Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria. Allergy Asthma Clin Immunol. 2019;15:15 pubmed publisher
Karowicz Bilinska A, Kowalska Koprek U, Estemberg D, Sikora Szubert A. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy. Ginekol Pol. 2018;89:142-146 pubmed publisher
Sehgal L, Mathur R, Braun F, Wise J, Berkova Z, Neelapu S, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 2014;28:2376-87 pubmed publisher
Chang J, Zhang G, Zhang L, Hou Y, Liu X, Zhang L. High admission glucose levels increase Fas apoptosis and mortality in patients with acute ST-elevation myocardial infarction: a prospective cohort study. Cardiovasc Diabetol. 2013;12:171 pubmed publisher
Deftereos S, Giannopoulos G, Kossyvakis C, Kaoukis A, Raisakis K, Driva M, et al. Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules. Am J Cardiol. 2010;105:54-8 pubmed publisher
Zhao W, Xu L, Wang L, Zhang L, Zhang Z, Liu Y, et al. A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction. Apoptosis. 2009;14:1204-11 pubmed publisher
Mrugacz M. Fas expression in conjunctival epithelial cells of patients with cystic fibrosis. J Interferon Cytokine Res. 2009;29:735-40 pubmed publisher
Niessner A, Hohensinner P, Rychli K, Neuhold S, Zorn G, Richter B, et al. Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J. 2009;30:789-96 pubmed publisher
Perez Andres M, Almeida J, Martin Ayuso M, de las Heras N, Moro M, Martín Nuñez G, et al. Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease. Int J Cancer. 2009;124:367-75 pubmed publisher
Kourea K, Parissis J, Farmakis D, Panou F, Paraskevaidis I, Venetsanou K, et al. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure. Atherosclerosis. 2008;199:215-21 pubmed
Svatek R, Herman M, Lotan Y, Casella R, Hsieh J, Sagalowsky A, et al. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer. Cancer. 2006;106:1701-7 pubmed
Parissis J, Adamopoulos S, Karatzas D, Paraskevaidis J, Livanis E, Kremastinos D. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy. Eur J Cardiovasc Prev Rehabil. 2005;12:164-8 pubmed
Zhang L, Li Y, Zhang H, Chen M, Gao M, Hu A, et al. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction. Eur J Clin Invest. 2005;35:164-70 pubmed
Alter P, Maisch B. Escape from cardiomyocyte apoptosis by enterovirus persistence due to elevated soluble Fas-receptors. Z Kardiol. 2004;93:524-32 pubmed
Lee T, Wu M, Chen M, Chao K, Ho H, Yang Y. Nitric oxide is associated with poor embryo quality and pregnancy outcome in in vitro fertilization cycles. Fertil Steril. 2004;82:126-31 pubmed
Mahovic D, Petravic D, Petelin Z, Zurak N, Horvat G, Hajnsek S. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis. Clin Neurol Neurosurg. 2004;106:230-2 pubmed
Dziankowska Bartkowiak B, Waszczykowska E, Zalewska A, Sysa Jedrzejowska A. Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement. Mediators Inflamm. 2003;12:339-43 pubmed
product information
brand :
R&D Systems
master code :
DFS00
SKU :
DFS00
product name :
Human Fas/TNFRSF6/CD95 Quantikine ELISA Kit
description :
The Human Fas/TNFRSF6/CD95 Quantikine ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human Fas/TNFRSF6/CD95 in cell culture supernates (100 ul), serum (10 ul), edta plasma (10 ul), heparin plasma (10 ul), citrate plasma (10 ul).
target :
Fas/TNFRSF6/CD95
category :
ELISAs
sizes available :
1 Kit
species :
Human
specificity :
Natural and recombinant human sFas
gene symbol :
FAS
kit type :
Solid Phase Sandwich ELISA
assay length :
4.5 hours
elisaSensitivity :
20 pg/mL
elisaRange :
31.20 - 2000 pg/mL
applications :
ELISA
USD :
615 USD
product details :
The Quantikine Human sFas Immunoassay is a 4.5 hour solid phase ELISA designed to measure human sFas in cell culture supernates, serum, and plasma. It contains recombinant human Fas/Fc chimera expressed from NS0 cells and antibodies raised against the recombinant factor. This immunoassay has been shown to accurately quantitate the recombinant factor. Results obtained measuring natural human sFas showed dose-response curves that were parallel to the standard curves obtained using the recombinant Fas/Fc chimera. These results indicate that this kit can be used to determine relative mass values for natural human sFas.
alt names :
Apo-1, Apo-1 antigen, apoptosis antigen 1, Apoptosis-mediating surface antigen FAS, APT1, APT1FASTM, CD95, CD95 antigen, CD95ALPS1A, Fas (TNF receptor superfamily, member 6), Fas AMA, Fas antigen, FAS1, FASLG receptor, TNFRSF6, TNFRSF6member 6, tumor necrosis factor receptor superfamily member 6
storage :
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.